Efficacy of WARTNER anti-wart local drug on genital warts
Phase 3
- Conditions
- Genital wart.Anogenital (venereal) warts
- Registration Number
- IRCT138811073200N1
- Lead Sponsor
- Manoosha-Daru
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Male sex, >= 18 years old of age, at least 2 genital wart lesion approved by dermatologist, consent to participate and being followed for visits, consent to discontinue the other anti-genital wart drugs
Exclusion criteria: diagnosed case of diabetes mellitus, Drug addiction, Other STDs, HIV positive, other immunodeficiency diseases, active skin lesion in genital ares, serious adverse event or intolerance to previous cryotherapy , cold sensitivity history, any tattoo, scar or pigmentation in the field of intervention which could affect the evaluation of the site, Being in the waiting list or participation in another cryotherpy trial at the same time of our study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intervention and control lesion size. Timepoint: Days 0 and 14. Method of measurement: Caliper and Camera.
- Secondary Outcome Measures
Name Time Method Clearance of lesion. Timepoint: Day 14. Method of measurement: Observation and photography.;Adverse event. Timepoint: 2 weeks after intervention. Method of measurement: Patient information.;Lesion recurrence. Timepoint: 6 weeks after intervention. Method of measurement: observation.